Reevaluating the Use of Guaifenesin in the Management of Acute Cough Associated With the Common Cold
Despite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.
Yoseph Raja, PharmD
Advertisement
Articles by Yoseph Raja, PharmD
Advertisement
Latest Updated Articles
Reevaluating the Use of Guaifenesin in the Management of Acute Cough Associated With the Common ColdPublished: September 21st 2020 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Pass-Through Rebate Law Uncovering New PBM Tactics, Entities | NCPA 2025
2
Community Pharmacies Need to Better Prioritize Whole-Person Health Care | NCPA 2025
3
American Pharmacists Month: Pharmacist Barriers, Expansion of Scope Since the COVID-19 Pandemic
4
Eli Lilly, Walmart Announce Expansion of Direct-to Consumer Access for Tirzepatide
5
